Skip to Content
MayoACCESS
MayoLINK
Register
My Dashboard
Test Catalog
Algorithms
Download Test Catalog & Interpretive Handbook
New Tests
NY State Informed Consent Tests
Performing Locations
Referred Tests
Specialty Testing
Test Updates
Ordering & Results
Critical Values & Results
Custom Gene Ordering
Forms
LIS Resources
MayoACCESS Resources
MayoLINK Resources
Order Your First Test
Patient Information and Signature Forms
Request Additional Testing
Send Additional Specimen
Specimen Handling
Collection & Preparation
Dangerous Goods Training
Shipping & Courier Guides
Shipping Regulations
Supplies
Customer Service
Billing
Contact Us
FAQ
IT Updates
Joint Test Catalog Admin Resources
Operational Updates
Quality & Compliance
Education & Insights
Educational Resources
News
Outreach
Podcasts
Stories
Contact
Log Out
Return to Answers From the Lab
Lab Legislation Update: Dr. Bill Morice
By
Meghann Southwick
•
May 19, 2022
Share this:
Related Episodes
Accelerating Research and Development With BioPharma Diagnostics
By
Sarah Jarvis
•
December 4, 2025
Unlocking the Unknown With Metagenomics
By
Sarah Jarvis
•
November 20, 2025
Forging Collaborations That Deliver Better Outcomes
By
Sarah Jarvis
•
November 6, 2025
Meghann Southwick
Meghann Southwick is a marketing specialist for Mayo Clinic Laboratories. She has worked at Mayo Clinic since 2021.
Related Posts
Real-time Quaking-induced Conversion Assays: From prion disease to emerging neurodegenerative diagnostics
Grateful for your trust
New Year’s 2025 Specimen Shipping Guidelines and Schedule
